Search results
Results from the WOW.Com Content Network
The term oncofertility refers to an interdisciplinary field that bridges oncology, reproduction, and women’s health research for the purpose of exploring and expanding options for the reproductive future of cancer patients. Clinical care for such patients may include fertility preservation prior to medical interventions as well as family ...
The Fund developed an online Medscape Continuing Medical Education (CME) course for medical professionals on breast cancer treatment options. The Cancer Prevention and Treatment Fund is a 510(c)(3) organization that has been recognized as one of America's Best Charities by Independent Charities of America. It is a member of CancerCure of ...
In developed countries, about 99% of breast cancer cases are diagnosed in female patients; in a few African countries, which represent the highest incidence of male breast cancer, males account for 5–15% of cases. [4] The rate of male breast cancer appears to be rising somewhat. [9] Male breast cancer patients tend to be older than female ...
For premium support please call: 800-290-4726 more ways to reach us
Breast cancer isn’t just a concern for older women. Learn about the rising risk among younger women and the steps to prioritize early detection and health.
Breast Cancer Care is the only specialist UK-wide charity in the UK providing care, support and information to anyone affected by breast cancer. The charity's headquarters are in London, with additional offices in Sheffield, Cardiff, and Glasgow. It is regularly quoted by media looking for the perspective of patients on breast cancer. [1]
Anixa’s vaccine is a three-shot series being tested initially in breast cancer survivors, who generally have a higher recurrence rate, and targets a particular protein involved in lactation ...
Komen works on patient navigation and advocacy, providing resources for breast-cancer patients to understand the American medical system. [5] They have funded research into the causes and treatment of breast cancer. [6] However, the organization has been mired by controversy over pinkwashing, allocation of research funding, and CEO pay. The ...